Effects of Antibodies on Arthritis in Mice
Author Information
Author(s): Matsumoto Isao, Zhang Hua, Yasukochi Takanori, Iwanami Keiichi, Tanaka Yoko, Inoue Asuka, Goto Daisuke, Ito Satoshi, Tsutsumi Akito, Sumida Takayuki
Primary Institution: University of Tsukuba
Hypothesis
The study aims to identify the cytokines and co-stimulatory molecules involved in the development of glucose-6-phosphate isomerase (GPI)-induced arthritis.
Conclusion
TNF-α and IL-6 are important in GPI-induced arthritis, and therapies targeting these cytokines may be effective for rheumatoid arthritis.
Supporting Evidence
- Anti-TNF-α mAbs and CTLA-4Ig suppressed TNF-α production.
- A single injection of anti-TNF-α and anti-IL-6 mAbs reduced arthritis severity.
- Anti-IFN-γ and anti-IL-12 mAbs tended to exacerbate arthritis.
- High serum levels of TNF-α and IL-6 were found in arthritic mice.
Takeaway
The study found that certain antibodies can help reduce arthritis in mice, which might help us understand how to treat arthritis in people.
Methodology
DBA/1 mice were immunized with GPI, and various antibodies were administered to assess their effects on arthritis severity.
Participant Demographics
Male DBA/1 mice aged 6 to 8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website